Lucas Franki is an associate editor for MDedge News, and has been with the company since 2014. He has a BA in English from Penn State University and is an Eagle Scout.
News
Pegboard test useful in upper-extremity motor assessments in Parkinson’s
The test may be a quick and objective marker of progression in Parkinson’s patients.
News
Clinical trial: Mesh Type in Ventral Hernia Repair
A clinical trial compares outcomes for biologic and synthetic mesh in ventral hernia repair patients.
News
Robotic-assisted IHR causes fewer complications in obese patients
Robotic-assisted surgery proves beneficial in inguinal hernia repair.
News
FDA approves new panel to identify mCRC patients for panitumumab treatment
The Food and Drug Administration has approved the Praxis Extended RAS Panel for the identification of metastatic colorectal cancer patients who...
News
FDA approves betrixaban for VTE prophylaxis
An orally administered agent has been approved for VTE prophylaxis in at risk hospitalized patients.
News
EASL publishes new PBC guidelines
Diagnosis, treatment, and management are addressed in the new guideline.
News
BMS recalls a lot of Eliquis 5 mg tablets
The Eliquis 5 mg lot, distributed nationwide, contains the wrong dosage.
News
Mesh use for lap paraesophageal hernia repair held steady
Is the use of mesh in PEHR nothing more than a waste of money?
News
Sjögren’s syndrome most common extrahepatic PBC manifestation
Up to 73% of PBC patients also have Sjögren’s syndrome.
News
ABP 501 equivalent in efficacy to adalimumab for moderate to severe RA
Treatments for RA continue to evolve with a newly approved adalimumab biosimilar.
News
FDA approves Rebinyn for hemophilia B treatment
Rebinyn is intended to control and treat bleeding episodes, as well as provide perioperative management of bleeding.
News
FDA approves generic Strattera for pediatric, adult ADHD patients
Generic atomoxetine will help more people in need find treatment.
News
Alzheimer’s mortality in U.S. grew from 1999 to 2014
Mortality rose dramatically in some states and ethnicities.
News
FDA approves sarilumab for DMARD-intolerant RA patients
The drug is the first to target the interleukin-6 receptor.
News
FDA approves first specific treatment for giant cell arteritis
The approval of tocilizumab was made with breakthrough therapy and priority review designations.